Table 11.
Transepidermal water loss value changes
| BG11001 |
Placebo |
p1) | p2) | ||
|---|---|---|---|---|---|
| Arbitrary units (Average ± SD) | |||||
| Tewa-meter | Baseline | 14.29 ± 2.60 | 14.94 ± 3.25 | 0.332 | |
| After 8 wk | 13.67 ± 2.47 | 15.16 ± 3.98 | 0.051 | 0.062 | |
| Difference3) | −0.62 ± 1.79 | 0.22 ± 2.47 | 0.091 | ||
| p4) | 0.039 | 0.580 | |||
| After 16 wk | 13.68 ± 2.62 | 14.96 ± 3.73 | 0.083 | 0.109 | |
| Difference5) | −0.61 ± 0.96 | 0.02 ± 2.56 | 0.154 | ||
| p4) | 0.000∗∗ | 0.958 | |||
| After 24 wk | 13.75 ± 2.92 | 15.30 ± 3.12 | 0.027 | 0.030* | |
| Difference6) | −0.53 ± 1.81 | 0.36 ± 2.57 | 0.081 | ||
| p4) | 0.073 | 0.391 | |||
∗p < 0.05 by Student t-test for comparison with placebo group.
∗∗p < 0.01 by Student t-test for comparison with placebo group.
Compared between groups: p by Student t-test.
Compared between groups: p-value by analysis of covariance (adjustment with baseline).
After 8 wk – baseline.
Compared within groups: p-value by paired t-test.
After 16 wk – baseline.
After 24 wk – baseline.